Seasoned Medical Device Executive Joins Breakthrough Structural Heart Company CAESAREA, ISRAEL AND AGOURA HILLS, CALIFORNIA – V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with...
Funds Support Further Development of V-Wave Implantable Interatrial Cardiac Shunt for Heart Failure and Pulmonary Hypertension CAESAREA, ISRAEL AND AGOURA HILLS, CALIFORNIA – V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive...
CE Mark for the Ventura™ Interatrial Shunt System is a significant milestone for V-Wave, as it recognizes that this therapeutic product conforms to the standards of the European Medical Device Directive V-Wave Ltd., a privately held medical device company developing...
CE Mark for the Ventura™ Interatrial Shunt System is a significant milestone for V-Wave, as it recognizes that this therapeutic product conforms to the standards of the European Medical Device Directive V-Wave Ltd., a privately held medical device company developing...
FDA Breakthrough Device Designation is granted to devices that have the potential to offer a “more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases.” V-Wave Ltd., a privately held medical device company developing novel...
Recent Comments